Dr. Msaouel provides an overview of SUO presentation on adjuvant therapy for high-risk non-metastatic RCC

“My talk [highlights] unmet research needs that need to be addressed to further improve the adjuvant treatment landscape for our patients,” said Pavlos Msaouel, MD, PhD.

In this video, Pavlos Msaouel, MD, PhD, discusses the key points of his presentation, “The future of adjuvant therapy for high-risk non-metastatic RCC,” presented during the 2021 Society of Urologic Oncology Annual Meeting. Msaouel is an assistant professor in the department of genitourinary medical oncology of the division of cancer medicine at the University of Texas MD Anderson Cancer Center in Houston, Texas.